Certain eye drops can measurably affect blood sugar levels, though most people using common over-the-counter lubricating drops have nothing to worry about. The eye drops that matter are prescription medications, particularly beta-blockers used for glaucoma and corticosteroid drops used after eye surgery or for inflammation. These drugs reach the bloodstream through absorption pathways most patients never think about, and for people with diabetes, the effects on glucose can be clinically significant.
How Eye Drops Get Into Your Bloodstream
The eye is small, and a single drop of medication contains far more active ingredient than the eye itself can absorb. The excess liquid has to go somewhere. Some of it spills onto your skin. Some drains through the tear ducts into the nasal cavity, where thin, highly vascular mucous membranes absorb the drug directly into the bloodstream. This nasal route is especially efficient because the drug bypasses the liver’s first-pass metabolism, meaning it enters circulation at full strength, much the way a sublingual tablet does.
The concentration of active ingredients in eye drops is often surprisingly high relative to the amount of tissue being treated. Even when you apply the recommended single drop correctly, considerable amounts can be absorbed systemically through these unintended routes.1PubMed Central. Systemic side effects of eye drops: a pharmacokinetic perspective For most healthy adults, the quantity that reaches the bloodstream is too small to cause noticeable whole-body effects. But for people with diabetes, or for anyone on medications that already influence glucose, even a small systemic dose of the wrong drug class can tip the balance.
Beta-Blocker Eye Drops and Hypoglycemia
Timolol is the most widely prescribed beta-blocker eye drop, commonly used to lower eye pressure in glaucoma. Oral beta-blockers are well known for masking the warning signs of low blood sugar, and it turns out that the eye drop version does the same thing once enough of the drug enters the bloodstream.
A case reported in a patient with insulin-dependent diabetes showed that ophthalmic timolol dangerously altered the way the body responded to low blood sugar. Before and after timolol therapy, this patient’s hypoglycemic episodes came with typical warning signs like sweating and uneasiness, and the episodes resolved promptly when the patient consumed glucose. During timolol treatment, those familiar warning symptoms disappeared. Instead, low blood sugar showed up as altered mental status, including seizures, and the episodes were harder to reverse with glucose.2PubMed. Ophthalmic timolol treatment causing altered hypoglycemic response in a diabetic patient That is a frightening shift: the drug did not just blunt the alarm bells, it changed the character of the emergency itself.
In another case, a 65-year-old man with insulin-dependent diabetes experienced more frequent and more severe hypoglycemic attacks while using timolol eye drops for glaucoma. When the drops were stopped, the hypoglycemic episodes ceased.3PubMed. Hypoglycemia due to ophthalmic timolol in a diabetic The pattern was consistent enough that the drug was clearly the trigger.
Beta-blockers do not typically raise or lower blood sugar on their own. What they do is suppress the adrenaline-driven symptoms that normally alert you to a drop in glucose, things like a racing heart, shakiness, and sweating. If you rely on those signals to know when to eat or adjust your insulin, losing them can be dangerous. The fact that a simple eye drop can suppress them is something many patients and even some prescribers underestimate.
Steroid Eye Drops and Rising Blood Sugar
Corticosteroid eye drops, especially dexamethasone and prednisolone, are routinely prescribed after cataract surgery, for uveitis, and for other inflammatory eye conditions. Oral and injected steroids are infamous for pushing blood sugar up, and here too the topical versions can follow suit once enough drug is absorbed systemically.
One study compared diabetic patients using dexamethasone eye drops after surgery with diabetic patients using the non-steroidal alternative diclofenac. The dexamethasone group saw blood glucose rise from about 170 mg/dL before surgery to about 229 mg/dL one month later. That increase was statistically significant and was also meaningfully higher than the glucose levels in the diclofenac group at the same time point.4PubMed. Effect of dexamethasone eyedrops on blood glucose profile A jump of roughly 60 mg/dL over a month is the kind of shift that could push someone from manageable diabetes into territory where medication adjustments become necessary.
The picture gets a bit more nuanced when you look at another study examining short-term, intensive dexamethasone eye drop use. In that study, the overall group of diabetic patients did not show a statistically significant change in blood glucose. But when the researchers looked specifically at patients whose diabetes was well controlled at baseline (fasting glucose at or below 135 mg/dL), those patients did show a significant glucose increase during steroid treatment. The rise reversed after the drops were stopped. Patients whose diabetes was poorly controlled at the outset did not show the same pattern.5PubMed. The effect of intense, short-term topical dexamethasone disodium phosphate eyedrops on blood glucose level in diabetic patients One possible explanation is that patients with already-high glucose had less room for a steroid-induced bump to stand out statistically, or that their glucose regulation was already too erratic for a small additional push to be detectable.
A study of prednisolone acetate eye drops in an Indian population found a similar short-term rise in fasting blood sugar at the one-week mark after surgery, which then returned to pre-treatment levels by the one-month follow-up.6Journal of Clinical Ophthalmology and Research. Effect of prednisolone acetate eye drops on blood glucose profile in Indian population That reassuringly temporary rise still matters if you are monitoring your glucose closely or making insulin dosing decisions during that window.
The takeaway across these studies is that steroid eye drops can bump your blood sugar, but the effect is usually transient and reverses when the drops are discontinued. For people without diabetes, the increase is unlikely to be clinically meaningful. For people with diabetes, the rise is worth knowing about so you can monitor more closely during treatment.
Who Faces the Highest Risk
Three groups are disproportionately vulnerable to systemic effects from eye drops: older adults, children, and people managing multiple health conditions simultaneously.
Older adults face the highest risk for several compounding reasons. Chronic eye diseases like glaucoma are more common with age, meaning long-term use of medicated drops. Older patients are also more likely to have cardiovascular, respiratory, or neurological conditions that can be worsened by systemically absorbed eye medications. And polypharmacy, taking multiple prescription drugs at once, raises the risk of drug interactions that neither the patient nor any individual prescriber may anticipate.7PubMed. Systemic adverse effects of topical ophthalmic agents. Implications for older patients If you are taking an oral beta-blocker for blood pressure and then add a beta-blocker eye drop for glaucoma, you have effectively increased your total beta-blocker dose without anyone necessarily adjusting for it.
Children are at risk for a different reason: eye drop doses are not weight-adjusted. A single drop of timolol delivers the same milligrams of drug whether it lands in a 90-kilogram adult’s eye or a 15-kilogram child’s. Combined with differences in liver development and drug metabolism, children face a much higher relative dose per kilogram than adults do.1PubMed Central. Systemic side effects of eye drops: a pharmacokinetic perspective
For people with diabetes specifically, the concern is not just that eye drops add a small systemic effect. It is that small perturbations in glucose, whether from masked hypoglycemia with beta-blockers or steroid-driven hyperglycemia, sit on top of a system that is already being carefully managed. A healthy person’s pancreas compensates for a slight glucose rise from steroid absorption without them ever noticing. A person whose insulin sensitivity or insulin production is already compromised may not have that buffer.
Reducing Systemic Absorption at Home
The good news is that a simple physical technique can dramatically reduce how much eye drop medication reaches your bloodstream. It is called nasolacrimal occlusion: after putting in a drop, you gently press a finger against the inner corner of your eye (near the nose) and hold it there for one to two minutes. This blocks the tear duct, preventing the drug from draining into the nasal cavity where it would otherwise be rapidly absorbed. Research consistently shows that this technique both improves the amount of drug that stays in the eye and reduces unwanted systemic absorption.8PubMed Central. The importance of eyelid closure and nasolacrimal occlusion following the ocular instillation of topical glaucoma medications, and the need for the universal inclusion of one of these techniques in all patient treatments and clinical studies
The trouble is that many patients find nasolacrimal occlusion awkward, especially if they have arthritis or limited dexterity. A newer alternative called the “tissue press method” works by pressing a folded tissue against the inner corner of the closed eye after drop instillation. In a crossover trial comparing the two approaches, the tissue press method was equally effective at reducing plasma timolol levels. Neither blood pressure, heart rate, nor eye pressure differed between the two techniques.9PubMed. New technique to reduce systemic side effects of timolol eye drops: The tissue press method-Cross-over clinical trial If pressing a finger against your tear duct feels clumsy, a tissue folded against the inner corner of your closed eye accomplishes the same thing.
Simply closing your eyes for a minute or two after putting in a drop, without any pressure, also helps. The eyelid closure slows drainage and gives the drug more time to absorb into the eye rather than running off. For anyone with diabetes who uses medicated eye drops regularly, either technique is worth building into routine.
Topical Insulin Drops and Blood Sugar
This one trips people up. Insulin eye drops are being studied for corneal healing problems, especially in people with diabetic corneal disease. You might assume that putting insulin directly onto the eye would cause blood sugar to drop, since insulin’s whole job is lowering glucose. It does not.
A systematic review of studies using topical insulin for corneal healing found that all but two of the included studies reported no local or systemic side effects, and insulin drops did not affect systemic blood glucose levels.10PubMed Central. Topical Insulin for Neurotrophic-Related Epithelial Defects: Where do We Stand? A Systematic Review Researchers have actually been testing this idea since 1931, when Christie and Hanzal first tried topical ocular insulin as a way to control blood sugar. The approach does not work for glucose management. The amount of insulin that crosses from the eye’s surface into the bloodstream is simply too small to move the needle on blood glucose, and subsequent studies in both humans and animals have consistently confirmed this.11medRxiv. Evaluating the Safety and Efficacy of Topical Insulin for Ocular Disease: A Systematic Review
The corneal healing benefits that researchers do see appear to happen at the cellular level, with insulin acting directly on the eye’s surface cells rather than working through any systemic change. This is reassuring for patients who might worry about hypoglycemia from an insulin-containing eye drop.
How Preservatives Change the Equation
Most multi-dose eye drops contain preservatives to prevent contamination, and the most common one, benzalkonium chloride, does more than just kill bacteria. It also disrupts the eye’s surface barriers in ways that increase how much drug (and other molecules) can pass through the cornea and the surrounding tissue into the bloodstream.
In animal studies, benzalkonium chloride dramatically enhanced the corneal penetration of both small-molecule drugs like beta-blockers and larger molecules like proteins. For certain larger compounds, corneal permeability increased by roughly 30 to 37 times.12PubMed. Ophthalmic preservatives as absorption promoters for ocular drug delivery That is an enormous change, and it means the preservative itself is partly determining how much drug reaches your bloodstream.
This becomes relevant to blood sugar in an interesting way. When researchers applied insulin to the eyes of rabbits, the addition of benzalkonium chloride and paraben (another common preservative) significantly increased the serum concentration of insulin that reached the bloodstream. The absorbed insulin then produced a corresponding drop in blood glucose.13Biological and Pharmaceutical Bulletin. Effect of Ophthalmic Preservatives on Serum Concentration and Local Irritation of Ocularly Applied Insulin The promoting effect of benzalkonium chloride was reversible and depended on the concentrations of both the preservative and the insulin in the formulation.14PubMed. Effect of preservatives on systemic delivery of insulin by ocular instillation in rabbits
These are animal findings, and the insulin doses used were experimental, not the concentrations found in the corneal-healing drops discussed above. But the principle is worth knowing: the preservative in your eye drops is not metabolically inert. It is actively altering how much of the active ingredient, and potentially other substances in the formulation, crosses into systemic circulation. For preserved formulations of drugs that already carry glucose-related risks (like beta-blockers or steroids), the preservative may amplify the systemic dose you actually receive.
Glaucoma Drugs With Unexpected Glucose Effects in Animal Research
Most of the research on eye drops and blood sugar focuses on beta-blockers and steroids, but other drug classes have shown unexpected metabolic effects in laboratory studies. Latanoprost, a prostaglandin analog widely used for glaucoma, was tested in mouse models of diabetes and obesity. Chronic administration decreased fasting blood glucose, HbA1c, fructosamine, and cholesterol levels, and improved glucose tolerance.15PubMed. Latanoprost effectively ameliorates glucose and lipid disorders in db/db and ob/ob mice
Before anyone gets excited about their glaucoma drops doubling as a diabetes treatment, these were mouse studies using laboratory models, not clinical observations in humans using standard eye drop doses. The systemic exposure from a single daily eye drop of latanoprost in a person is far smaller than what was administered in these animal experiments. Still, it is a reminder that the metabolic reach of ophthalmic drugs may be wider than traditionally assumed, and it is the kind of finding that researchers are watching as they try to understand the full pharmacological profile of drugs millions of people use every day.
When to Talk to Your Doctor
If you have diabetes and are prescribed any new eye drop, particularly beta-blocker drops for glaucoma or steroid drops after eye surgery, it is worth flagging your diabetes explicitly. Ophthalmologists obviously know your eye history but do not always have your full medication list or endocrine picture in front of them. Specifically:
- Beta-blocker drops: Ask whether a non-beta-blocker alternative exists if you have a history of hypoglycemic episodes. Prostaglandin analogs and other drug classes can lower eye pressure without the beta-blocker-related glucose-masking risk.
- Steroid drops: Plan to monitor your blood sugar more frequently during the course of treatment and for a week or so after stopping. The glucose bump is usually temporary, but catching it early means you can adjust insulin or oral medications in time.
- Nasolacrimal occlusion: Practice the tear-duct pressure technique or the tissue press method with every medicated drop, especially if you use drops daily for a chronic condition.
Over-the-counter artificial tears and lubricating drops, the kind people use for dry eyes, contain no active pharmaceutical ingredients that would influence blood sugar. If your drops are simply saline or carboxymethylcellulose or hyaluronic acid, glucose is not a concern. The risk lives in prescription medications with known systemic pharmacological activity, and the connection is well documented enough that it should be part of the conversation every time a person with diabetes starts a new ophthalmic drug.